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In a recent article published in
Intensive Care Medicine, Doig et al.
[1] describe a systematic review
assessing the value of early enteral
nutrition in the intensive care unit.
The last paragraph of the paper begins
‘‘Meta-analysis conducted on the
methodologically sound clinical trials
identiﬁed by our systematic review of
the literature revealed a statistically
signiﬁcant reduction in mortality
and pneumonia attributable to the
provision of standard EN within
24 h of injury.’’
‘‘Methodologic soundness’’ was
deﬁned as trials that were free of
major methodological ﬂaws, namely
pseudo-randomization (because of the
loss of concealment of allocation) and
[10% loss to follow-up. (Although
the investigators also assessed the
trials for any element of blinding,
blinding itself did not appear to be a
criterion for inclusion.) Six such trials
(Chiarelli 1990, Chuntrasakul 1996,
Kompan 1999, Pupelis 2001, Kompan
2004, Nguyen 2008) were identiﬁed
and employed in the meta-analyses.
Even for these reports, Doig et al. in
the Validity appraisal of the Results
section, acknowledged that it was
unclear if allocation concealment was
accomplished (in addition to noting
that there was no instance where
blinding was done). Hence, the
methodologic soundness only depen-
ded on the single criterion of\10%
loss to followup.
The situation is more problematic.
In the Methods section of Chiarelli
1990 [2], it is stated that the 20
patients were ‘‘randomly assigned to
one of two groups by the case-control
method.’’ That method is not
explained. The term ‘‘case-control’’
usually refers to an observational (and
retrospective) study, not a prospective
randomized one. If this study was
prospective, one possible meaning of
‘‘case-control’’ is that the patients
were assigned alternately; if so, there
would be no concealment of alloca-
tion. Given the description by
Chiarelli et al. how can we be sure
that this was a properly randomized
trial?
The Pupelis 2001 trial is also prob-
lematic [3]. As Doig et al. noted, there
was an earlier report of this trial [4]; in
that report, 11 patients were in the
enteral nutrition group and 18 in the
control group. In the ﬁnal report, there
were 30 patients in each arm, meaning
that, in the period following the pre-
liminary report, 19 and 12 patients
were enrolled into treatment and con-
trol groups. If this trial was
randomized, a patient had a 50%
chanceofbeingassignedtoeitherarm.
The likelihood that at least 18 of 29
patientswouldbe assignedtothesame
arm is about 26%. Similarly, the like-
lihoodthat no more than 11 of the next
31 would be assigned to the same arm
is14%.Thus,theprobabilityofhaving
these events occur back to back is
14 9 26%, or\4% (equivalent to a
p value\0.04). There is concern that,
at least for the second half of the trial,
the randomization was somehow
distorted. It may even be that this
trial was not randomized at all.
There is a separate confounding
factor in three of the other trials
(Chuntrasakul 1996, Kompan 1999,
Kompan 2004), namely a dispropor-
tionate use of parenteral nutrition.
There is evidence that parenteral
nutrition increases the risk of infec-
tions [5]. Both protocols by Kompan
et al. [6, 7] called for parenteral
nutrition to be given to the entire
control group beginning on the ﬁrst
day. In the Chuntrasakul trial, paren-
teral nutrition supplementation was
given to enteral nutrition recipients
when the enteral intake was ‘‘insufﬁ-
cient’’; the control patients received
nutritional support by ‘‘conventional
method’’ (not deﬁned) [8]. Thus, in
all three trials, the use of parenteral
nutrition became a confounding issue.
The problem with the randomized
trials in the entire enteral nutrition
literature is the absence of method-
ologic soundness, resulting in high
risks of bias. Trials with high risks
of bias typically overestimate pur-
ported treatment beneﬁts [9]. Claims
to the contrary notwithstanding, the
evidence cited by Doig et al. is not
methodologically sound. As such, it
is not capable of supporting the
claim that enteral nutrition reduces
mortality and pneumonia in the
critically ill.
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